MiMedx.
biomedical company based in Marietta, Georgia, founded in 2008
- Reports this week
- 0
- Active events
- 0
- Connections
- 42
What's happening
One to three months ago
-
CMS proposed a sweeping overhaul of reimbursement policies on July 31, 2025.Some support2 reports2 developments inside
-
Trades are taking place on the Nasdaq stock exchange involving MiMedx.Some support3 reports
-
MiMedx has acquired Sanara MedTech for $350 million, combining their portfolios.Some support3 reports
Gone quiet
No new reports in 90+ days-
Brokerage firms issued consensus recommendations regarding MiMedx on July 29, 2025.Some support1 report
-
MiMedx senior management participated in a conference hosted by Cantor on August 27, 2025.Some support1 report
-
Trump's pledge to unleash oil and gas is reported to benefit MiMedx stock.Some support1 report
-
MiMedx invested in Vaporox, a Denver-based company, and Vaporox's Vaporous Hyperoxia Therapy received 510(k) clearance from the FDA for its wound care offerings.Some support1 report
-
MiMedx reported that its free cash flow significantly exceeded statutory profit and its accrual ratio was negative as of August 7, 2025.Some support1 report
-
MiMedx Group is based in Marietta, Georgia, and CMS has proposed reimbursement reforms for skin substitutes.Well supported3 reports
-
MiMedx attended a symposium in Las Vegas on September 3, 2025. Paul Kim and Nicolas Mouawad were faculty members at the event.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around MiMedx this week
News at the entities that move MiMedx most-
Renaissance Technologies TransactionalRenaissance Technologies holds a significant stake in Lite Strategy, Inc., whose stock trades on the Nasdaq exchange.Moves MiMedx
-
Raymond James Financial TransactionalRaymond James Financial reiterated an outperform rating on FinWise Bancorp.Moves MiMedx
-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves MiMedx
-
Cantor Fitzgerald OperationalAnalyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Moves MiMedx
-
TipRanks Mentioned togetherTipRanks reported on insider buying activity concerning Howard Hughes Holdings Inc. on September 25, 2026.Moves MiMedx
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves MiMedx
Connections
The 10 strongest of 42, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Renaissance Technologies Transactional
Renaissance Technologies increased its financial stake in MiMedx.
-
Nasdaq Structural
MiMedx operates as a publicly traded company on the Nasdaq stock exchange.
-
Raymond James Financial Transactional
RIF issued a target price for MiMedx, indicating a market assessment of potential value or future transaction.
-
Securities and Exchange Commission Structural
MiMedx operates under the oversight and regulatory framework of the Securities and Exchange Commission.
-
Cantor Fitzgerald Operational
Cantor Fitzgerald provides ongoing financial ratings and market analysis for MiMedx stock.
-
TipRanks Mentioned together
TipRanks provides financial analysis and consensus data regarding MiMedx.
-
MediWound (Germany) Operational
MediWound and MiMedx are collaborating and supporting each other in clinical trials.
-
Northland Mentioned together
Northland tracks MiMedx's market drivers, and MiMedx attends Northland's capital growth conferences.
Show all 10 connections
-
New York Mentioned together
No evidence links New York to MiMedx; the company is based in Marietta, Georgia.
-
MarketAxess Mentioned together
Evidence is insufficient to establish a coupled relationship between MarketAxess and MiMedx.
History
Events by the month they beganAugust 2026
1 eventJune 2026
8 events- CMS proposed a sweeping overhaul of reimbursement policies on July 31, 2025.
- Brokerage firms issued consensus recommendations regarding MiMedx on July 29, 2025.
- MiMedx senior management participated in a conference hosted by Cantor on August 27, 2025.
- Trump's pledge to unleash oil and gas is reported to benefit MiMedx stock.
- MiMedx invested in Vaporox, a Denver-based company, and Vaporox's Vaporous Hyperoxia Therapy received 510(k) clearance from the FDA for its wound care offerings.
- MiMedx reported that its free cash flow significantly exceeded statutory profit and its accrual ratio was negative as of August 7, 2025.
- MiMedx Group is based in Marietta, Georgia, and CMS has proposed reimbursement reforms for skin substitutes.
- MiMedx attended a symposium in Las Vegas on September 3, 2025. Paul Kim and Nicolas Mouawad were faculty members at the event.